Ultralife (NASDAQ:ULBI) Lowered to “Buy” at StockNews.com

StockNews.com cut shares of Ultralife (NASDAQ:ULBI) from a strong-buy rating to a buy rating in a research note issued to investors on Saturday.

Separately, Benchmark increased their price target on shares of Ultralife from $13.00 to $14.00 and gave the company a buy rating in a report on Thursday, June 27th.

Ultralife Stock Performance

Shares of ULBI stock traded down $0.30 on Friday, reaching $10.81. The stock had a trading volume of 142,289 shares, compared to its average volume of 89,993. The company has a quick ratio of 2.06, a current ratio of 4.07 and a debt-to-equity ratio of 0.07. The firm’s 50-day moving average is $10.85 and its two-hundred day moving average is $9.86. The firm has a market capitalization of $179.66 million, a price-to-earnings ratio of 16.89 and a beta of 0.99. Ultralife has a 12 month low of $6.36 and a 12 month high of $13.39.

Ultralife (NASDAQ:ULBI) last issued its earnings results on Thursday, July 25th. The technology company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.08. The company had revenue of $42.98 million for the quarter. Ultralife had a net margin of 5.96% and a return on equity of 9.32%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Quadrature Capital Ltd bought a new position in Ultralife in the 1st quarter valued at about $200,000. Empowered Funds LLC increased its holdings in shares of Ultralife by 7.8% during the first quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock worth $277,000 after purchasing an additional 2,275 shares during the period. O Shaughnessy Asset Management LLC bought a new position in shares of Ultralife during the first quarter worth approximately $100,000. Visionary Wealth Advisors increased its holdings in shares of Ultralife by 0.9% during the fourth quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock worth $7,381,000 after purchasing an additional 9,997 shares during the period. Finally, Hillsdale Investment Management Inc. bought a new position in shares of Ultralife during the first quarter worth approximately $166,000. 30.68% of the stock is owned by institutional investors.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.